Literature DB >> 2506168

Purification and characterization of recombinant human interleukin 5 expressed in Chinese hamster ovary cells.

M Tsujimoto1, H Adachi, S Kodama, N Tsuruoka, Y Yamada, S Tanaka, S Mita, K Takatsu.   

Abstract

Recombinant human interleukin 5 (rhIL-5) expressed in Chinese hamster ovary cells was purified and characterized. Molecular heterogeneity was observed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Two major components of Mr around 40,000 were detected under non-reducing conditions. However, under reducing conditions, the Mr of rhIL-5 was determined to be 22,000 and 20,000. After treatment with endoglycosidase F, a band with an apparent Mr of 18,000 was observed. Treatment of rhIL-5 with 2-mercaptoethanol followed by N-ethylmaleimide resulted in its dissociation into a monomeric form. This alkylated rhIL-5 was biologically less active than intact rhIL-5. These results suggest that rhIL-5 exists as a dimer, and that the heterogeneity of rhIL-5 is mainly due to the difference in the content of carbohydrate. Moreover, the formation of disulfide bond(s) might be important for the biological activity of rhIL-5.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506168     DOI: 10.1093/oxfordjournals.jbchem.a122812

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

1.  Preparation and characterization of human interleukin-5 expressed in recombinant Escherichia coli.

Authors:  A E Proudfoot; D Fattah; E H Kawashima; A Bernard; P T Wingfield
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

2.  Interleukin-4 regulates the interleukin-2 receptors on human peripheral blood B lymphocytes.

Authors:  K Tomizawa; A Ishizaka; K Kojima; M Nakanishi; Y Sakiyama; S Matsumoto
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

3.  Cloning and expression of the defective genes from a patient with delta-aminolevulinate dehydratase porphyria.

Authors:  N Ishida; H Fujita; Y Fukuda; T Noguchi; M Doss; A Kappas; S Sassa
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

4.  IL-4 down-regulates the surface expression of CD5 on B cells and inhibits spontaneous immunoglobulin and IgM-rheumatoid factor production in patients with rheumatoid arthritis.

Authors:  T Hidaka; A Kitani; M Hara; M Harigai; K Suzuki; Y Kawaguchi; T Ishizuka; M Kawagoe; H Nakamura
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

5.  Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist.

Authors:  J Tavernier; T Tuypens; A Verhee; G Plaetinck; R Devos; J Van der Heyden; Y Guisez; C Oefner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

6.  High level expression of a frog alpha-amidating enzyme, AE-II, in cultured cells and silkworm larvae using a Bombyx mori nuclear polyhedrosis virus expression vector.

Authors:  J Kobayashi; S Imanishi; H Inoue; K Ohsuye; K Yamaichi; N Tsuruoka; S Tanaka
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

7.  Human interleukin-5 expressed in Escherichia coli has N-terminal modifications.

Authors:  K Rose; P O Regamey; R Anderegg; T N Wells; A E Proudfoot
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

8.  Characterization of interleukin 5 receptors on eosinophilic sublines from human promyelocytic leukemia (HL-60) cells.

Authors:  G Plaetinck; J Van der Heyden; J Tavernier; I Faché; T Tuypens; S Fischkoff; W Fiers; R Devos
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.